CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced presentations at the European Society for Medical Oncology …
Read More »
INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into an agreement to …
Read More »
ANN ARBOR–Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
PHILADELPHIA – Treating the brain with a preventative course of radiation may help Small Cell …
Read More »
SOUTH PLAINFIELD, N.J., March 16, 2017 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it …
Read More »
AstraZeneca today announced that the US Food and Drug Administration (FDA) has issued a Complete …
Read More »
THOUSAND OAKS, Calif., March 14, 2017 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that four-year follow-up …
Read More »
Morris Plains, N.J., March 15, 2017 — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or “the Company”) …
Read More »
DUBLIN and CAMBRIDGE, Mass., March 14, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global …
Read More »
AstraZeneca today presented results from the Phase III SOLO-2 trial demonstrating a significant improvement in …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced …
Read More »
Basel, March 13, 2017 – The US Food and Drug Administration (FDA) has approved Kisqali®(ribociclib, …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food & …
Read More »
WALTHAM, Mass.–(BUSINESS WIRE)–Sobi, a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services …
Read More »
PRINCETON, N.J., March 06, 2017 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company …
Read More »
Holzkirchen, 6 March 2017 – Sandoz, a Novartis division, and the pioneer and global leader …
Read More »
SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ:CELG) today announced that results from its phase 4 UNVEIL trial …
Read More »
ALAMEDA, Calif., March 06, 2017 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
